Erythromycin/sulfafurazole: Difference between revisions
CSV import |
CSV import |
||
| Line 41: | Line 41: | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 11:18, 17 March 2025
Erythromycin/Sulfafurazole is a combination medication used in the treatment of various bacterial infections. It is a combination of two antibiotics: erythromycin, a macrolide antibiotic, and sulfafurazole, a sulfonamide antibiotic.
Mechanism of Action[edit]
Erythromycin works by inhibiting the synthesis of bacterial proteins, thereby preventing the growth and multiplication of bacteria. Sulfafurazole, on the other hand, inhibits the synthesis of folic acid, a vital component for bacterial DNA replication. The combination of these two antibiotics provides a broader spectrum of action against a variety of bacteria.
Indications[edit]
Erythromycin/Sulfafurazole is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the diseases listed below:
Side Effects[edit]
Like all medications, Erythromycin/Sulfafurazole can cause side effects. These may include:
Precautions[edit]
Patients with a history of allergy to macrolides or sulfonamides should avoid this medication. It should also be used with caution in patients with liver or kidney disease.
Interactions[edit]
Erythromycin/Sulfafurazole may interact with other medications, including warfarin, phenytoin, and certain antifungal medications. It is important to inform your healthcare provider of all medications you are currently taking.
References[edit]
